Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder
NCT00150605 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2007-11-02
Summary
The purpose of this study is to evaluate the safety of SPD417 when given with other psychotropic medications to treat bipolar I disorder.
Conditions
Interventions
- DRUG
-
Extended-release carbamazepine
Sponsors & Collaborators
-
Validus Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-02-28
- Completion
- 2005-10-31
More Related Trials
-
VALID : VAlproate Versus LIthium in Bipolar Disorders
NCT00264173 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression
NCT01396447 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder
NCT00563992 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.
NCT05169710 ·Status: TERMINATED ·Phase: PHASE3
-
An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
NCT00060905 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Combined Treatment for Young Bipolar I Disorder
NCT00976794 ·Status: COMPLETED ·Phase: PHASE4
-
A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder
NCT00195845 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Cariprazine for Bipolar I Disorder
NCT01058668 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Cariprazine for Mania
NCT01058096 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression
NCT02600507 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.
NCT00154323 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
NCT01822678 ·Status: COMPLETED ·Phase: PHASE2
-
Acute Treatment of Bipolar II Depression
NCT00074776 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
NCT07140913 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia
NCT04127058 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.
NCT00228059 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
NCT02670538 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression
NCT02670551 ·Status: COMPLETED ·Phase: PHASE3
-
An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder
NCT00106405 ·Status: COMPLETED ·Phase: PHASE2
-
A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features
NCT03573297 ·Status: COMPLETED ·Phase: PHASE3
-
Decision-Making in Bipolar Disorder
NCT01463111 ·Status: COMPLETED ·Phase: NA
-
Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder
NCT00194129 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder
NCT00299715 ·Status: COMPLETED ·Phase: PHASE3
-
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
NCT07288320 ·Status: RECRUITING ·Phase: PHASE2
-
Aripiprazole in the Treatment of Bipolar Depression
NCT00226317 ·Status: COMPLETED ·Phase: NA